EVMs to have candidates' photos

Bengaluru, Apr 7: With reporting of 12 positive cases of COVID-19 since last evening, including three women, the total number of confirmed cases in Karnataka increased to 175, including four deaths.

According to official sources, while three fresh cases of COVID-19 were reported from Bengaluru, two each had been reported from Bagalkot, Kalaburagi and Mandya, followed by one each at Gadag and Bengaluru Rural districts.

After a gap of over three weeks, two more fresh cases had been reported from Kalaburagi, which had reported the first death of the country.

Mangaluru, May 6: A day after a wild bison dies lost its life hours after being tranquilized in Mangaluru, another wild bison appeared in the Ashok Nagar area of the coastal city today.

In fact, two bison were spotted in Mangaluru yesterday. The two were reportedly wandering together early in the morning. Later one was spotted in Mannagudda and the other in Hathill area.

While one of them was tranquillized by an official of a Pilikula Biological Park and captured, another bison had gone missing.

The captured animal, however, died later in the day due to cardiac arrest.

According to official, it is common for herbivores, which are sedated to ensure their safe capture, to suffer cardiac arrest.

Meanwhile, Forest department officials have launched an operation to capture the second bison. It is believed that it is the same bison which went missing yesterday.

Also Read: Wild bison intrudes into Mangaluru city amidst lockdown; captured

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.